GLP-1 weight-loss drugs force employers to rethink health coverage
TL;DR Summary
Rising use of GLP-1 weight‑loss drugs is driving up employer health costs, with about two‑thirds of firms still covering GLP-1s but roughly 10% planning to drop coverage next year. PepsiCo, Cigna and Starbucks have already narrowed or halted GLP-1 coverage, while Bank of America reports hundreds of millions spent on these drugs; some research suggests fewer sick days, complicating the cost‑benefit equation for employers.
- America’s enthusiasm for weight-loss drugs is forcing employers to drop coverage The Independent
- GLP-1 use for weight loss significantly impacted by Massachusetts insurance changes, data shows CBS News
- Private health insurers covered 112,000 fewer Mass. residents’ GLP-1 weight-loss drugs this year, report finds The Boston Globe
- Coverage changes spark sharp decline in GLP-1 usage WWLP
- When determining GLP-1 coverage, keep these considerations in mind benefitnews.com
Reading Insights
Total Reads
1
Unique Readers
6
Time Saved
16 min
vs 17 min read
Condensed
98%
3,215 → 64 words
Want the full story? Read the original article
Read on The Independent